Guided Therapeutics (GTHP) Enterprise Value Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.91% |
| Sep 30, 2025 | 68.17% |
| Jun 30, 2025 | 25.42% |
| Mar 31, 2025 | 45.87% |
| Dec 31, 2024 | 15.50% |
| Sep 30, 2024 | 28.95% |
| Jun 30, 2024 | 33.19% |
| Mar 31, 2024 | 29.07% |
| Dec 31, 2023 | -48.08% |
| Sep 30, 2023 | -7.96% |
| Jun 30, 2023 | -21.19% |
| Mar 31, 2023 | -343.91% |
| Dec 31, 2022 | -37.03% |
| Mar 31, 2022 | -394.38% |
| Sep 30, 2021 | -97.71% |
| Jun 30, 2021 | -182.26% |
| Mar 31, 2021 | -154.11% |
| Dec 31, 2020 | -466.71% |
| Sep 30, 2020 | -98.75% |
| Jun 30, 2020 | -356.89% |
| Mar 31, 2020 | -175.89% |
| Dec 31, 2019 | -300.45% |
| Mar 31, 2019 | 52.50% |
| Sep 30, 2018 | 25.89% |
| Jun 30, 2018 | 72.51% |
| Mar 31, 2018 | -61.63% |
| Dec 31, 2017 | 81.66% |
| Sep 30, 2017 | -20.78% |
| Jun 30, 2017 | 74.54% |
| Mar 31, 2017 | 72.86% |
| Dec 31, 2016 | 71.63% |
| Sep 30, 2016 | 78.46% |
| Jun 30, 2016 | 77.69% |
| Mar 31, 2016 | 63.04% |
| Dec 31, 2015 | 67.77% |
| Sep 30, 2015 | 59.05% |
| Jun 30, 2015 | -13.90% |
| Mar 31, 2015 | 72.86% |
| Dec 31, 2014 | 57.40% |
| Sep 30, 2014 | 66.61% |
| Jun 30, 2014 | 40.85% |
| Mar 31, 2014 | 72.12% |
| Dec 31, 2013 | 42.14% |
| Jun 30, 2013 | -74.44% |